Overview
Nicotine is a powerful and addictive substance found naturally in tobacco plants. It is present in all forms of tobacco products, including traditional cigarettes, heated tobacco devices (also known as “heat-not-burn” products), cigars, smokeless forms like snuff, dip, snus, and chewing tobacco, as well as hookah and most electronic cigarettes.1
Using any type of tobacco can lead to dependence on nicotine. This happens because nicotine affects how the brain functions, leading to repeated cravings.2
Certain tobacco products—such as regular cigarettes—are designed to rapidly deliver nicotine to the brain, often within seconds, which can make users more likely to become addicted and less likely to stop.1
Nicotine binds to specific receptors in the brain known as nicotinic cholinergic receptors, leading to the release of dopamine and other neurotransmitters that produce psychoactive effects that are rewarding. The release of neurotransmitters such as dopamine, glutamate, and GABA plays a crucial role in the development of nicotine dependence, while corticotropin-releasing factor (CRF) is thought to be a key mediator in the manifestation of withdrawal symptoms.3
With repeated exposure, tolerance develops, diminishing nicotine’s initial rewarding impact and fostering physical dependence, evident through withdrawal symptoms when nicotine use is stopped.5 Smoking behaviour is influenced not only by nicotine’s pharmacological effects but also by external cues such as peer influence, stress, advertising, and smoking-associated environments.6 The rate at which nicotine is metabolised, primarily by the liver enzyme CYP2A6, also affects nicotine levels in the body and can influence individual smoking patterns.5
Other contributing factors include age, sex, genetic predisposition, mental health conditions, and concurrent substance use.6 Tobacco addiction arises from a complex mix of biological, behavioural, genetic, and environmental influences, including how nicotine products are formulated and marketed.5 Pharmacologically, nicotine use is often driven by its ability to elevate mood, relieve withdrawal symptoms, and enhance cognitive or physical performance.6
Nicotine and tobacco rank as the second most widely consumed psychoactive substances worldwide, surpassed only by caffeine. Globally, more than one billion individuals use tobacco products. While tobacco use has declined in many high-income nations, it remains prevalent or is even increasing in low- and middle-income regions. Cigarette smoking continues to be a major contributor to preventable illness and death, with approximately 480,000 fatalities in 2012 attributed to smoking-related conditions.1
Research indicates that withdrawal symptoms were reported by 61.3% of individuals who tried to quit smoking.2 Individuals who reported experiencing withdrawal symptoms were found to have lower success rates in quitting tobacco use.2 While public health campaigns have contributed to reduced cigarette smoking in wealthier nations, the emergence of e-cigarettes and vaping has created an alternative method for nicotine consumption, one that has gained popularity, particularly among younger demographics.1
Nicotine withdrawal symptoms
Withdrawal symptoms typically emerge within four to twenty-four hours after a person stops using nicotine-containing products regularly.2 These symptoms tend to reach their highest intensity around the third day and gradually lessen over the next three to four weeks.8 The way nicotine is delivered into the body plays a major role in how intense the withdrawal experience is.3 That said, recovery timelines can vary, and some individuals may continue to experience symptoms for a few months.3
Symptoms can differ from one individual to another but commonly include: nicotine cravings, anger, frustration, irritability, difficulty concentrating, insomnia, restlessness, anxiety, depression and increased appetite.2
Other, less common nicotine withdrawal symptoms include headaches, fatigue, dizziness, coughing, mouth ulcers, nightmares, nausea, sore throat and constipation.8
While nicotine withdrawal shares features with other substance withdrawal syndromes, it is uniquely characterized by weight gain and a reduction in heart rate.5 The intensity of withdrawal symptoms can vary and is influenced by how nicotine was consumed.3 The encouraging part is that these symptoms can be managed with the right strategies.2
Pharmacologic approaches in tobacco dependence
Nicotine's impact on the brain significantly contributes to the addictive nature of tobacco use.5 As such, pharmacologic interventions are a vital component in treating nicotine dependence. An ideal medication would not only diminish the pleasurable effects associated with nicotine use but also alleviate or prevent withdrawal symptoms.6 Additionally, the most effective pharmacologic agents would selectively target the specific nicotine receptor subtypes involved in addiction.6
Importance of nonpharmacologic strategies in smoking cessation
Tobacco dependence is a condition influenced by neurobiological, behavioural, psychological, and social factors.5 Because of this complexity, the most effective treatment strategies combine both medication and behavioural support.6 Non-drug interventions, such as counselling on an individual or group basis, are essential in addressing the behavioural conditioning and emotional triggers associated with tobacco use.4
Social support and nicotine withdrawal: How family, friends, and support groups can help
Nicotine withdrawal can be a difficult and daunting process, often accompanied by physical and emotional challenges that make quitting smoking feel overwhelming. In this journey, social support plays a crucial role in fostering successful smoking cessation. Social support refers to actions, behaviours, and emotional encouragement offered by others, which promote positive behavioural changes. It is categorised into two types: structural support, referring to the number of social connections one has, and functional support, which is the quality of these relationships.7
Support can take three main forms: emotional support (e.g., offering comfort and encouragement), informational support (e.g., giving advice or guidance), and instrumental support (e.g., helping to solve practical problems).7
In the context of quitting smoking, support can either be general or specifically focused on abstinence, aiming to assist individuals both broadly and in relation to the specific health behaviour of smoking cessation.7
The importance of social support in smoking cessation is well-documented through observational studies, which suggest that both general and abstinence-specific support from family, friends, and colleagues can significantly influence successful quitting. However, the effectiveness of social support often depends on the timing and the manner in which it is delivered.12
Research shows that supportive behaviours that are constructive, combined with a reduction in negative forms of support, can greatly assist in overcoming addiction. On the other hand, negative support, such as nagging or controlling behaviours, can undermine a smoker’s efforts. Interestingly, smokers themselves may sometimes offer more negative reinforcement than non-smokers, highlighting the delicate balance between support and its potential for harm.12
Particularly during the initial stages of cessation, positive social support is essential. There are several reasons why social support is linked to smoking behaviour. First, it directly encourages behaviour change by providing motivation and affirmation. Second, it serves as a model for healthy behaviour, offering both examples of desirable actions and warnings against unhealthy ones. Finally, social support can have indirect benefits by reducing daily stress, fostering a peaceful interpersonal environment, and promoting the use of healthier coping strategies—factors that are all vital for the successful cessation of smoking.7
Given the evidence supporting the connection between social support and successful quitting, smoking cessation programs are encouraged to incorporate strategies that enhance social support. These interventions can occur within the treatment setting (intra-treatment support) or outside it (extra-treatment support). Intra-treatment support occurs within the treatment process, where healthcare providers offer direct encouragement. Extra-treatment support, however, extends beyond the clinical environment and involves the resources available to smokers, such as family and friends, or support groups.
The role of extra-treatment social support
While the idea of involving significant others in the cessation process has gained popularity, studies have shown mixed results regarding the effectiveness of extra-treatment support. For example, some studies suggest that smokers have a higher chance of quitting when their partners attend treatment sessions with them, or when they are paired with "quit buddies" who are also trying to stop smoking.12 These benefits, however, tend to be short-lived and may be influenced by biases in observational studies.
When more rigorous study designs are employed, the effect of involving romantic partners or peers in the quitting process often appears less pronounced. Meta-analyses and systematic reviews generally fail to find significant evidence that extra-treatment social support significantly improves smoking cessation rates.12
While the inconsistency in findings could be partly due to small sample sizes and varying study methods, it underscores the need for further investigation into the potential benefits of peer and partner involvement.
The power of intra-treatment social support
In contrast, intra-treatment social support has proven to be a vital element in intensive behavioural interventions. Studies comparing group treatments to individual counselling have consistently shown that group therapy leads to higher success rates in smoking cessation. In fact, individuals who participate in group sessions are 1.38 to 2.27 times more likely to remain abstinent compared to those receiving one-on-one treatments. This effect is likely due to the social cohesion and support fostered within the group setting, where individuals share common experiences and encourage one another.7
The significance of intra-treatment support is further validated by experimental trials demonstrating that fostering a sense of commitment to a group significantly improves cessation outcomes. The collective support within these groups provides a network of emotional encouragement, accountability, and shared strategies, which are particularly beneficial in overcoming cravings and challenges.7
A study involving over seven thousand U.S. adult smokers revealed that those who utilised social support and behavioural interventions during their last quit attempt were significantly more likely to intend to quit smoking in the next six months. The odds of intending to quit were 39% higher among smokers who received social support and 36% higher among those who used behavioural interventions.7
Notably, certain groups, such as people assigned female at birth, individuals with higher education, and those using pharmacological aids, were more likely to utilise these support systems. The study emphasises the importance of encouraging social support, especially for underserved populations, and integrating support components into cessation programs.7
Approaching smoking cessation with sensitivity
Discussing smoking cessation with someone, especially when mental health concerns are involved, requires a delicate approach. Rather than focusing too early on smoking itself, it's essential to listen actively to the person's concerns, such as depression or stress. Using open-ended questions about the relationship between smoking and mood can create a space for the individual to reflect on their habits. Seeking permission to share information about smoking's impact on mental health is crucial to maintaining a supportive dialogue.9
If the person isn't yet considering quitting, it’s helpful to ask about their reasons for smoking, such as addiction or financial concerns. Highlighting personal values, such as the desire to be there for family, can serve as a motivational tool in shifting the conversation towards cessation. By offering support and debunking common myths about smoking, individuals can build self-confidence and begin to consider quitting.9
Digital platforms: A new form of support
With the rise of digital technology, individuals now have the opportunity to receive support through online forums and communities. Research examining social support on platforms like the QuitNow forum shows that emotional encouragement, esteem-based compliments, and practical advice are the most common forms of support exchanged among users, especially during the early stages of quitting. As time progresses, the type of support shifts, with network-related interactions becoming less frequent. These findings highlight the importance of tailoring online interventions to cater to individuals at various stages of their quit journey.10
Gender differences in peer support
Recent studies have also indicated that the effectiveness of peer support in smoking cessation may vary between genders. People assigned female at birth, in particular, seem to benefit more from consistent peer support, with regular encouragement significantly increasing their chances of quitting. This pattern is less evident in people assigned male at birth, suggesting that people AFAB may be more receptive to peer interactions during the quitting process. These gender differences emphasise the need for tailored support strategies to enhance the effectiveness of cessation programs.11
Conclusion: Creating an environment of support
During the challenging process of quitting smoking, it is essential to surround oneself with positive social support, whether from family, friends, support groups, or healthcare providers. Encouraging individuals to reach out for help when needed and providing them with the resources to manage cravings and emotional stress can significantly enhance their chances of success. Whether through in-person interactions or digital platforms, the support of loved ones and peers is a powerful tool in overcoming nicotine addiction and achieving long-term smoking cessation.
References
- U.S. Food and Drug Administration. Nicotine: Why tobacco products are addictive [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; [updated 2023 Oct 18; cited 2025 Apr 29]. Available from: https://www.fda.gov/tobacco-products/health-effects-tobacco-use/nicotine-why-tobacco-products-are-addictive#2
- Tips for Coping with Nicotine Withdrawal and Triggers - NCI [Internet]. 2022 [cited 2025 Apr 29]. Available from: https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/withdrawal-fact-sheet
- McLaughlin I, Dani JA, De Biasi M. Nicotine withdrawal. Curr Top Behav Neurosci. 2015;24:99–123. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4542051/
- Tips For Quitting | Quit Smoking | Tips From Former Smokers | CDC [Internet]. 2024[cited 2025 Apr 29]. Available from: https://www.cdc.gov/tobacco/campaign/tips/quit-smoking/tips-for-quitting/index.html
- Benowitz NL. Nicotine addiction. N Engl J Med. 2010 Jun 17;362(24):2295–303. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2928221/
- Benowitz NL. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med. 2008 Apr;121(4 Suppl 1):S3–10. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0002934308001034
- Soulakova JN, Tang CY, Leonardo SA, Taliaferro LA. Motivational benefits of social support and behavioural interventions for smoking cessation. J Smok Cessat. 2018 Dec;13(4):216–26. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6459678/#abstract1
- Regina AC, Gokarakonda SB, Attia FN. Withdrawal syndromes [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan [updated 2024 Sep 2; cited 2025 May 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459239/
- Taylor GMJ, Baker AL, Fox N, Kessler DS, Aveyard P, Munafò MR. Addressing concerns about smoking cessation and mental health: theoretical review and practical guide for healthcare professionals. BJPsych Adv. 2021 Mar;27(2):85–95. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7611646/#abstract1
- Struik L, Khan S, Assoiants A, Sharma RH. Assessment of social support and quitting smoking in an online community forum: study involving content analysis. JMIR Form Res. 2022;6(1):e34429. doi:10.2196/34429. PMID: 35023834; PMCID: PMC8796047. Available from: https://formative.jmir.org/2022/1/e34429
- Lee Westmaas J, Chantaprasopsuk S, Bontemps-Jones J, Stephens RL, Thorne C, Abroms LC. Longitudinal analysis of peer social support and quitting smoking: Moderation by sex and implications for cessation interventions. Preventive Medicine Reports. 2022;30:102059. doi:10.1016/j.pmedr.2022.102059. Available from: https://www.sciencedirect.com/science/article/pii/S2211335522003667#ab005
- Shahab L. Smoking cessation interventions involving significant others: the role of social support. 2012. National Centre for Smoking Cessation and Training (NCSCT). Available from: https://www.ncsct.co.uk/library/view/pdf/Briefing%205.pdf

